8Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J]. N Engl J Med, 2002, 346(2): 92-98.
9Parra HS, Cavina R, Latteri F, et al. Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib("Iressa", ZD1839)in non-small-cell lung cancer [J]. BrJ Cancer, 2004, 91(2): 208-212.
10Fukuoka M,Yano S, Giaccone G, et al. Multi-institutional randomized phase lI trial of gefifinib for previously treated patients with advanced non-small--cell lung cancer(The IDEAL 1 Trial) corrected[J].J.Clin Oncol, 2003, 21(12): 2237-2246.